InChI=1S/C44H82NO8P/c1- 6- 8- 10- 12- 14- 16- 18- 20- 21- 22- 23- 25- 27- 29- 31- 33- 35- 37- 44(47) 53- 42(41- 52- 54(48,49) 51- 39- 38- 45(3,4) 5) 40- 50- 43(46) 36- 34- 32- 30- 28- 26- 24- 19- 17- 15- 13- 11- 9- 7- 2/h20- 21,23,25,29,31,42H,6- 19,22,24,26- 28,30,32- 41H2,1- 5H3/b21- 20- ,25- 23- ,31- 29- /t42- /m1/s1 |
XMZFUVYOYPLVOA-VLHUWQDUSA-N |
[C@@H](COC(CCCCCCCCCCCCCCC)=O)(COP(OCC[N+](C)(C)C)(=O)[O-])OC(CCC/C=C\C/C=C\C/C=C\CCCCCCCC)=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 36:3 )
|
|
View more via ChEBI Ontology
Outgoing
|
1-hexadecanoyl-2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphocholine
(CHEBI:86119)
has functional parent
(5Z,8Z,11Z)-icosatrienoic acid
(CHEBI:72865)
1-hexadecanoyl-2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphocholine
(CHEBI:86119)
has functional parent
hexadecanoic acid
(CHEBI:15756)
1-hexadecanoyl-2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphocholine
(CHEBI:86119)
is a
1-palmitoyl-2-icosatrienoyl-sn-glycero-3-phosphocholine
(CHEBI:133631)
|
|
(2R)- 3- (hexadecanoyloxy)- 2- {[(5Z,8Z,11Z)- icosa- 5,8,11- trienoyl]oxy}propyl 2- (trimethylazaniumyl)ethyl phosphate
|
1-hexadecanoyl-2-(5Z,8Z,11Z-eicosatrienoyl)-sn-glycero-3-phosphocholine
|
UniProt
|
1- hexadecanoyl- 2- [(5Z,8Z,11Z)- eicosatrienoyl]- sn- glycero- 3- phosphocholine
|
ChEBI
|
1-palmitoyl-2-meadoyl-GPC
|
ChEBI
|
1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)
|
ChEBI
|
1-Palmitoyl-2-meadoyl-sn-glycero-3-phosphocholine
|
HMDB
|
GPC(16:0/20:3n9)
|
ChEBI
|
GPCho(16:0/20:3)
|
HMDB
|
GPCho(16:0/20:3n9)
|
HMDB
|
GPCho(16:0/20:3w9)
|
HMDB
|
PC(16:0/20:3(5Z,8Z,11Z))
|
LIPID MAPS
|
PC(16:0/20:3)
|
HMDB
|
PC(16:0/20:3n9)
|
HMDB
|
PC(16:0/20:3w9)
|
HMDB
|
PC(36:3)
|
HMDB
|
Phosphatidylcholine(16:0/20:3)
|
HMDB
|
Phosphatidylcholine(16:0/20:3n9)
|
HMDB
|
Phosphatidylcholine(16:0/20:3w9)
|
HMDB
|
Phosphatidylcholine(36:3)
|
HMDB
|
24023812
|
PubMed citation
|
Europe PMC
|
|